To include your compound in the COVID-19 Resource Center, submit it here.

FDA publishes review of cancer accelerated approvals

Over half of all cancer therapies approved under FDA’s accelerated assessment pathway since its inception have verified their clinical benefit, according to a review from FDA's Office

Read the full 277 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE